The Linkage between Metachronous Thyroid and Breast Cancers: An Illustrative Case
Mohamed Dhaha1*, Sawsen Dhambri1, Aymen Ferjaoui2, Rihab Lahmar1, Souheil Jbali1, Skander Kedous1, Slim Touati1 and Said Gritli1
1Head and Neck Surgery Department, Salah Azaez Oncology Institute, Tunis, Tunisia
2Department B, Maternity and Neonates Center of Tunis, Tunis, Tunisia
*Corresponding Author: Mohamed Dhaha, Head and Neck Surgery Department, Salah Azaez Oncology Institute, Tunis, Tunisia.
Received:
May 11, 2021; Published: May 26, 2021
Abstract
Breast cancer (BC) is the most common cancer in women. Thyroid cancer (TC) is relatively rare with female predominance. These two malignancies often occur metachronously. This association is no more a simple coincidence. However, the reasons behind this association are not well elucidated.
We report a case of metachronous breast and thyroid cancer occurring in a postmenopausal woman. It was an invasive ductal carcinoma for the breast and anaplastic cancer for the thyroid.
We tried to find out what might be the linkage between these two malignancies.
Keywords: Thyroid; Breast; Metachronous Cancers
References
- Chalstrey LJ and Benjamin B. “High incidence of breast cancer in thyroid cancer patients”. British Journal of Cancer4 (1966): 670-675.
- Kim C., et al. “The risk of second cancers after diagnosis of primary thyroid cancer is elevated in thyroid microcarcinomas”. Thyroid5 (2013): 575-582.
- Evans HS., et al. “Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England”. British Journal of Cancer3 (2001): 435-440.
- Nielsen SM., et al. “The Breast-Thyroid Cancer Link: A Systematic Review and Meta-analysis”. Cancer Epidemiology, Biomarkers and Prevention 2 (2016): 231-238.
- Garner CN., et al. “Increased prevalence of breast cancer among patients with thyroid and parathyroid disease”. Surgery6 (2007): 806-813.
- Lee KD., et al. “Increased risk for second primary malignancies in women with breast cancer diagnosed at young age: a population-based study in Taiwan”. Cancer Epidemiology, Biomarkers and Prevention 17.10 (2008): 2647-2655.
- Zhang L., et al. “Characteristics and survival of patients with metachronous or synchronous double primary malignancies: breast and thyroid cancer”. Oncotarget (2016).
- Bolf EL., et al. “A Linkage Between Thyroid and Breast Cancer: A Common Etiology?” Cancer Epidemiology, Biomarkers and Prevention 4 (2019): 643-649.
- Raymond J and Hogue C. “Multiple primary tumours in women following breast cancer, 1973–2000”. British Journal of Cancer11 (2006): 1745-1750.
- Van Leeuwen F and Travis L. “Second cancers”. Cancer: Principles and Practice of Oncology 2 (2005): 2773-2796.
- Zheng G., et al. “Familial associations of female breast cancer with other cancers”. International Journal of Cancer11 (2017): 2253-2259.
- Puzianowska-Kuznicka M., et al. “Functionally impaired TR mutants are present in thyroid papillary cancer”. The Journal of Clinical Endocrinology and Metabolism 3 (2002): 1120-1128.
- Portella G., et al. “Development of mammary and cutaneous gland tumors in transgenic mice carrying the RET/PTC1 oncogene”. Oncogene 9 (1996): 2021-2026.
- Zeng Q., et al. “Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen receptor-ERK pathway”. Cell Proliferation 406 (2007): 921-935.
- Manole D., et al. “Estrogen Promotes Growth of Human Thyroid Tumor Cells by Different Molecular Mechanisms 1”. The Journal of Clinical Endocrinology and Metabolism3 (2001): 1072-1077.
- Teng CJ., et al. “Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study”. Journal of the National Cancer Institute2 (2016).
- Harvie M., et al. “Can diet and lifestyle prevent breast cancer: what is the evidence?” American Society of Clinical Oncology (2015): e66-73.
- Ma J., et al. “Obesity and risk of thyroid cancer: evidence from a meta-analysis of 21 observational studies”. Medical Science Monitor 21 (2015): 283-291.
- Smyth PP. “The thyroid, iodine and breast cancer”. Breast Cancer Research5 (2003): 235-238.
- Sinnott B., et al. “Exposing the thyroid to radiation: a review of its current extent, risks, and implications”. Endocrine Reviews5 (2010): 756-773.
- Schlumberger M., et al. “[Thyroid cancer following exposure to ionising radiation]”. Cancer Radiotherapy5 (2011): 394-399.
- Ghosh S., et al. “A rare case of a synchronous anaplastic carcinoma thyroid with ductal carcinoma breast”. Case Reports in Oncological Medicine (2014): 468159.
- Zhang Y., et al. “Risk of second primary breast cancer after radioactive iodine treatment in thyroid cancer: a systematic review and meta-analysis”. Nuclear Medicine Communications2 (2016): 110-115.
Citation
Copyright